Latest News and Press Releases

         Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed February 2, 2024Company announcement No. 07 On January 29, 2024, following the satisfaction of...

Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks...

6% organic sales growth in Q4 and 5% for the full year with solid margins and free cash flow generation As Novozymes just closed the combination with Chr. Hansen on January 29, and the annual...

         Total number of voting rights and capital on January 31, 2024 January 31, 2024Company announcement No. 05  Referring to company announcement 02, on January 29, 2024, where Novozymes A/S...

         January 29, 2024Company announcement No. 04  Trading by management and close relations of management    In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on...

                  Major shareholder announcement January 29, 2024Company announcement No. 03     On January 29, 2024, following the satisfaction of all conditions precedent, the combination of...

Today, the proposed combination of the legacy companies Novozymes and Chr. Hansen is successfully completed, establishing the company Novonesis. Novonesis is a world-leading biosolutions partner for...

Please read the full announcement in PDF Attachment 2024_02_Completion_Of_The_Combination ...

Please read the full announcement in PDF Attachment 2024_01_All_Regulatory_Approvals_Obtained ...

Please read the full announcement in the attached PDF Attachment 2023_South Korean merger approval granted ...